Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive ...
Intel's stock is down after Lip-Bu Tan failed to offer quick fixes in a recent speech. But analysts saw positive aspects to his approach in the new role. Intel Corp. Chief Executive Lip-Bu Tan just ...
19h
Barchart on MSNAnalysts Say the ‘Anti Elon Musk Crowd’ Will Hurt Tesla in the ‘Near Term.’ Should You Buy or Sell TSLA Stock Here?Tesla (TSLA) has always been a company that sparks both excitement and debate, and its recent challenges have only added fuel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results